Adaptive Biotechnologies Corp (NASDAQ:ADPT)

8.12
Delayed Data
As of Nov 25
 -0.18 / -2.17%
Today’s Change
5.96
Today|||52-Week Range
30.51
-71.06%
Year-to-Date

Stock Price Forecast

The 7 analysts offering 12-month price forecasts for Adaptive Biotechnologies Corp have a median target of 12.00, with a high estimate of 18.00 and a low estimate of 7.00. The median estimate represents a +47.78% increase from the last price of 8.12.

Analyst Recommendations

The current consensus among 9 polled investment analysts is to Buy stock in Adaptive Biotechnologies Corp. This rating has held steady since August, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.35
Sales
$55.1M
Reporting Date
Mar 01

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -9.18%
 
 
 
 
 
 
Growthannually 0.43%
 
 
 
 
 

Sales

Growthquarterly 15.12%
 
 
 
 
 
 
Growthannually 20.15%
 
 
 
 
 
Key to the earnings and sales forecast charts.